EderleJFeatherstoneRLBrownMM. Percutaneous transluminal angioplasty and stenting for carotid artery stenosis. Cochrane Database Syst Rev. 2007;(4):CD000515.
2.
EcksteinHHRinglebPAllenbergJR. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol. 2008;7:893–902.
3.
SilverFLMackeyAClarkWM.; CREST Investigators. Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). Stroke. 2011;42:675–680.
4.
ArquizanCTrinquartLTouboulPJ.; EVA-3S Investigators. Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study. Stroke. 2011;42:1015–1020.
5.
BonatiLHEderleJMcCabeDJ. Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomized trial. Lancet Neurol. 2009;8:908–917.
6.
BekelisKMosesZMissiosS. Indications for treatment of recurrent carotid stenosis. Br J Surg. 2013;100:440–447.
7.
van LammerenGWPeetersWde VriesJP. Restenosis after carotid surgery: the importance of clinical presentation and preoperative timing. Stroke. 2011;42:965–971.
YadavJSWholeyMHKuntzRE. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493–1501.
10.
FokkemaMde BorstGJNolanBW. Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy. J Vasc Surg. 2014;59:8–15 e1–2.
11.
AbuRahmaAFAbu-HalimahSHassSM. Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis. J Vasc Surg. 2010;52:1180–1187.
12.
FokkemaMVrijenhoekJEDen RuijterHM. Stenting versus endarterectomy for restenosis following prior ipsilateral carotid endarterectomy: an individual patient data meta-analysis. Ann Surg. 2015;261:598-604.
13.
WasserKSchnaudigelSWohlfahrtJ. Clinical impact and predictors of carotid artery in-stent restenosis. J Neurol. 2012;259:1896-1902.
14.
TepeGLairdJSchneiderP. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation. 2015;131:495-502.
15.
MatheyDGWendigIBoxbergerM. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial. EuroIntervention. 2011;7(suppl K):K61-K65.
16.
SchellerBCleverYPKelschB. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5:323–330.
17.
MontorsiPGalliSRavagnaniPM. Drug-eluting balloon for treatment of in-stent restenosis after carotid artery stenting: preliminary report. J Endovasc Ther. 2012;19:734–742.
GandiniRDel GiudiceCDa RosV. Long-term results of drug-eluting balloon angioplasty for treatment of refractory recurrent carotid in-stent restenosis. J Endovasc Ther. 2014;21:671–677.
20.
PiccoliGBiondi-ZoccaiGGavrilovicV. Drug-coated balloon dilation before carotid artery stenting of post–carotid endarterectomy restenosis. J Endovasc Ther. 2015;22:212–216.
21.
TekieliLPieniazekPMusialekP. Zotarolimus-eluting stent for the treatment of recurrent, severe carotid artery in-stent stenosis in the TARGET-CAS population. J Endovasc Ther. 2012;19:316-324.
